Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

370 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nonalcoholic Fatty Liver Disease and Mortality.
Stefan N. Stefan N. Clin Gastroenterol Hepatol. 2018 Jul;16(7):1043-1045. doi: 10.1016/j.cgh.2018.02.016. Epub 2018 Feb 21. Clin Gastroenterol Hepatol. 2018. PMID: 29474973 No abstract available.
Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver.
Lehmann R, Franken H, Dammeier S, Rosenbaum L, Kantartzis K, Peter A, Zell A, Adam P, Li J, Xu G, Königsrainer A, Machann J, Schick F, Hrabé de Angelis M, Schwab M, Staiger H, Schleicher E, Gastaldelli A, Fritsche A, Häring HU, Stefan N. Lehmann R, et al. Among authors: stefan n. Diabetes Care. 2013 Aug;36(8):2331-8. doi: 10.2337/dc12-1760. Epub 2013 Mar 20. Diabetes Care. 2013. PMID: 23514731 Free PMC article.
Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial.
Stefan N, Ramsauer M, Jordan P, Nowotny B, Kantartzis K, Machann J, Hwang JH, Nowotny P, Kahl S, Harreiter J, Hornemann S, Sanyal AJ, Stewart PM, Pfeiffer AF, Kautzky-Willer A, Roden M, Häring HU, Fürst-Recktenwald S. Stefan N, et al. Lancet Diabetes Endocrinol. 2014 May;2(5):406-16. doi: 10.1016/S2213-8587(13)70170-0. Epub 2014 Feb 17. Lancet Diabetes Endocrinol. 2014. PMID: 24795254 Clinical Trial.
An extended fatty liver index to predict non-alcoholic fatty liver disease.
Kantartzis K, Rettig I, Staiger H, Machann J, Schick F, Scheja L, Gastaldelli A, Bugianesi E, Peter A, Schulze MB, Fritsche A, Häring HU, Stefan N. Kantartzis K, et al. Among authors: stefan n. Diabetes Metab. 2017 Jun;43(3):229-239. doi: 10.1016/j.diabet.2016.11.006. Epub 2017 Jan 12. Diabetes Metab. 2017. PMID: 28089502 Free article.
Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study.
Schmid V, Wagner R, Sailer C, Fritsche L, Kantartzis K, Peter A, Heni M, Häring HU, Stefan N, Fritsche A. Schmid V, et al. Among authors: stefan n. Diabetologia. 2017 Dec;60(12):2341-2351. doi: 10.1007/s00125-017-4407-z. Epub 2017 Aug 24. Diabetologia. 2017. PMID: 28840257
370 results